On October 20, 2026, a four-member delegation from French HTL Biotechnology visited Singclean Medical for an exchange and factory tour. This significant meeting aimed to deepen the strategic cooperation between the two parties in the application of premium hyaluronic acid (HA) raw materials and global brand promotion, jointly exploring new growth opportunities for premium injectable HA in the global market.

The HTL delegation was highly distinguished, comprising Ms. Nathalie Chevallon (Chief Public Affairs & Communication Officer from HTL France HQ), Mr. Clement GEORGPUX (Product Manager), Ms. Evon (Head of Asia-Pacific Marketing), and Mr. Jia Wenqiang (China Sales Manager).

During the meeting, Singclean Medical presented its global industrial layout and cutting-edge R&D capabilities, with a special focus on the Singfiller Cross-linked Sodium Hyaluronate Gel series, crafted with HTL's premium raw materials. In today's highly competitive HA market with fierce product homogenization, Singfiller (Lift and Silk versions) has built a differentiated core competitiveness based on its top-tier raw material base and patented formulation technology. It has received wide acclaim from clinical physicians for its smoother injection experience and lower redness/swelling rates.
The HTL delegation shared their core strengths: as a world-leading pharmaceutical-grade HA raw material supplier with over 30 years of heritage, HTL utilizes an exclusive patented bacterial fermentation process to produce fibrous pharmaceutical-grade HA. This material features ultra-high purity, excellent safety, and long-lasting stability, with strictly controlled impurity levels. Backed by authoritative international registrations such as CEP and USDMF, it solidifies the product's foundation from the source, delivering safer, longer-lasting, and naturally comfortable injection experiences for consumers.

Following the meeting, the HTL delegation toured the production workshop for Singfiller. They witnessed the Class 100 cleanroom environment, German Optima aseptic filling equipment, Swedish Getinge sterilization systems, and fully automated inner packaging lines. This full-chain high-standard production system ensures sterile, controllable, and stable quality throughout the entire process. The HTL delegation highly praised Singclean's rigorous production quality control system and world-class smart manufacturing capabilities.
This visit marks a powerful alliance between a global top-tier raw material giant and a leading medical aesthetics manufacturer. Empowered by HTL's top-tier raw materials and combined with Singclean Medical's mature R&D transformation, world-class smart manufacturing, and global market operation system, Singfiller is backed by multiple layers of strength. In the future, both parties will deepen synergy and global promotion, continuously providing doctors and consumers worldwide with safe, reliable, and highly effective premium injectable fillers, jointly defining a new quality benchmark for global medical aesthetics HA.
-
singclean | 2026-10-20
Singclean Medical: 15 Years of Chongyang Care — 2026 Event Reaches 337 Elderly Residents Across 6 CommunitiesIn 2011, during the Chongyang Festival—a traditional Chinese occasion dedicated to respecting the elderly—Singclean Medical first entered local communities to deliver cooking oil, rice, and other daily necessities to senior residents. That simple act of care has never stopped. For 15 consecutive years, the company has continued this tradition, bringing warmth and support to the elderly every autumn. -
singclean | 2026-10-20
Singclean to Exhibit at MEDICA 2026 in Germany, Booth Hall 16 / F67-5Singclean, a global leader in healthcare solutions, today announced its participation in MEDICA 2026, one of the world's largest medical B2B trade fairs. The event will take place from November 16th to 19th, 2026, at the Düsseldorf Exhibition Centre in Germany. Singclean will showcase its latest innovations at Booth No. Hall 16 / F67-5. -
singclean | 2026-10-20
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。